Clinical Trial Update: A Single Ascending Dose Study To Assess The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of AZD9567. [Phase 1]

View source ↗

Summary

Phase 1 single-ascending-dose study to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of AZD9567 in healthy subjects (with mention of rheum…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• AZD9567 (AZD9567)

Snippet

Sponsor: AstraZeneca | Conditions: Safety, Tolerability | Phase 1 | Status: COMPLETED | Results posted: 2018-10-04